Zurn Elkay (NYSE: ZWS) director granted 503 shares as fees
Rhea-AI Filing Summary
Zurn Elkay Water Solutions director Rosemary Schooler reported receiving 503 shares of common stock on January 15, 2026. The shares were acquired at a reference price of $47.27 per share as payment of director fees in the form of restricted stock units. According to the filing, these units vested immediately but will not be paid out until six months after she ceases serving as a director.
After this grant, Schooler beneficially owns 58,344 shares of Zurn Elkay common stock, held directly. The transaction is coded as an acquisition and reflects equity-based compensation rather than an open-market purchase.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Zurn Elkay (ZWS) report for Rosemary Schooler?
Rosemary Schooler, a director of Zurn Elkay Water Solutions, reported an acquisition of 503 shares of common stock on January 15, 2026, shown as equity compensation.
How many Zurn Elkay (ZWS) shares did Rosemary Schooler receive and at what price?
She received 503 shares of Zurn Elkay common stock at a reference price of $47.27 per share, as recorded in the Form 4.
Why did Rosemary Schooler receive 503 Zurn Elkay (ZWS) shares?
The footnote states the shares represent payment of director fees in restricted stock units, which vested immediately and are payable six months after she stops serving as a director.
When do Rosemary Schooler’s restricted stock units in Zurn Elkay get paid out?
The restricted stock units vested immediately but are not paid out until six months after Rosemary Schooler’s cessation of service as a director.
How many Zurn Elkay (ZWS) shares does Rosemary Schooler own after this transaction?
Following the reported transaction, Rosemary Schooler beneficially owns 58,344 shares of Zurn Elkay common stock, held directly.
Was the Zurn Elkay (ZWS) Form 4 transaction an acquisition or a sale?
The Form 4 lists the transaction code as "A" for acquisition, indicating that shares were acquired as compensation rather than sold.